Entera Bio Ltd.

Minrav Building – Fifth Floor

Jerusalem, Israel 9112002

June 4, 2025

VIA EDGAR
United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C. 20549

Attention: Jason Drory

RE:	Entera Bio Ltd. (the “Company”)
	Registration Statement on Form S-3 (the “Registration Statement”)
	Filed May 30, 2025
	File No. 333-287676

Dear Mr. Drory:

The Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration Statement so that such Registration Statement will become effective as of 4:00 p.m. on June 6, 2025, or as soon thereafter as practicable.

[Signature page follows]

	Very truly yours,

	Entera Bio Ltd.

	By:	/s/ Miranda Toledano
		Name: Miranda Toledano
		Title: Chief Executive Officer